STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial

How 1 sources are covering this

• STATCenter·1h ago

  STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial

  Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.

  Read at STAT →